Trump Rx medication list includes select brand-name prescription drugs offered at reduced prices through TrumpRx.gov using direct manufacturer programs.
Examples include Ozempic, Wegovy, Zepbound, Januvia, Repatha, and Xeljanz for U.S. patients with valid prescriptions.
Trump Rx medication list has become a major point of attention in the United States as prescription drug pricing reform moves into a new phase under President Donald Trump’s administration. As of February 2026, TrumpRx.gov is live and operational, offering Americans a centralized way to find lower-priced prescription medications through direct manufacturer pricing programs. This long-form guide explains exactly what the Trump Rx medication list is, which drugs are included, how the system works, and what the latest confirmed updates mean for patients today.
What the Trump Rx Medication List Means in 2026
The Trump Rx medication list refers to prescription drugs that are available through TrumpRx, a federally branded prescription drug pricing portal. The platform does not function as a pharmacy. Instead, it allows users to search for medications and then directs them to pharmaceutical companies’ direct-to-consumer purchasing programs that offer reduced prices.
This initiative focuses on lowering out-of-pocket costs for Americans who struggle with high prescription prices, especially those who are uninsured, underinsured, or paying cash. The list continues to expand as manufacturers finalize pricing agreements and update their participation.
How TrumpRx Works for Patients
TrumpRx is designed to simplify price discovery and reduce reliance on traditional pharmacy pricing structures.
Here is how the system works in practice:
- Patients search for a medication on TrumpRx.gov
- The site displays available manufacturer pricing options
- Users are redirected to the drugmaker’s official purchasing platform
- A valid prescription from a licensed provider is required
- Medications are shipped directly to the patient or fulfilled through approved channels
TrumpRx does not replace insurance plans. Purchases made through the platform may not count toward insurance deductibles or annual out-of-pocket maximums.
Verified Trump Rx Medication List as of February 2026
The following medications are confirmed to be part of the TrumpRx initiative through direct pricing agreements, manufacturer participation, or inclusion on the live platform. This list reflects the most accurate information available at the time of writing.
GLP-1 Diabetes and Weight-Loss Medications
These drugs represent one of the most significant pricing changes under TrumpRx due to high demand and historically high costs.
- Ozempic – Type 2 diabetes and weight management
- Wegovy – Chronic weight management
- Zepbound – Obesity treatment
These medications are offered through manufacturer direct programs at substantially reduced monthly prices compared to traditional retail costs. Availability depends on prescription eligibility and supply constraints.
Diabetes and Metabolic Condition Medications
Several widely used diabetes treatments are included in the Trump Rx medication list:
- Januvia – Type 2 diabetes
- Jentadueto – Type 2 diabetes combination therapy
- Farxiga – Diabetes, heart failure, and kidney disease
These drugs are offered with simplified pricing models that eliminate multiple layers of pharmacy markups.
Cardiovascular and Cholesterol Medications
Heart disease remains a leading cause of death in the U.S., and TrumpRx includes medications commonly prescribed for cardiovascular conditions:
- Repatha – Cholesterol management
- Plavix – Blood clot prevention
Manufacturer pricing agreements have significantly lowered cash prices for eligible patients.
Autoimmune, Rheumatology, and Inflammatory Drugs
The Trump Rx medication list includes treatments for chronic autoimmune conditions that traditionally carry high costs:
- Xeljanz – Rheumatoid arthritis and autoimmune disorders
- Cosentyx – Inflammatory arthritis and psoriasis
- Orencia – Rheumatoid arthritis
These medications are typically specialty drugs, and TrumpRx pricing is aimed at improving access for long-term patients.
Dermatology and Skin Condition Treatments
Skin conditions are another focus area under TrumpRx pricing agreements:
- Eucrisa – Atopic dermatitis (eczema)
- Duavee – Menopause-related bone health
- Toviaz – Overactive bladder
These drugs are available at reduced prices through manufacturer programs linked on the platform.
Migraine and Neurology Medications
Neurological and migraine treatments included in the Trump Rx medication list include:
- Zavzpret – Acute migraine treatment
- Rexulti – Neurological and mental health conditions
Lower pricing is intended to support patients who require consistent treatment.
Infectious Disease and Respiratory Drugs
TrumpRx also includes medications for infectious diseases and respiratory conditions:
- Epclusa – Hepatitis C treatment
- Xofluza – Influenza antiviral
- Airsupra – Asthma treatment
These medications are made available under pricing structures designed to reduce barriers to timely treatment.
How Much Are Prices Reduced Under TrumpRx?
Exact prices vary by dosage, manufacturer, and supply conditions. However, confirmed pricing models under TrumpRx share several characteristics:
- Monthly costs are significantly lower than traditional retail prices
- Prices are often comparable to or lower than those in other developed countries
- There are no pharmacy benefit manager markups
- Discounts can exceed 50% for many brand-name drugs
For high-cost specialty medications, reductions may reach even higher levels depending on manufacturer agreements.
Who Benefits Most From the Trump Rx Medication List
The TrumpRx program is especially beneficial for:
- Uninsured individuals
- Patients with high-deductible insurance plans
- Cash-pay patients
- Individuals taking long-term or specialty medications
- Seniors who do not qualify for certain subsidy programs
Patients with comprehensive insurance coverage may still find lower costs through their existing plans, depending on copays and rebates.
What the Trump Rx Medication List Does Not Include
Despite its scope, TrumpRx has clear limitations:
- It does not prescribe medications
- It does not replace Medicare or private insurance
- Not all medications are included
- Generic drugs may still be cheaper at retail pharmacies
- Prices may change as agreements evolve
Patients are encouraged to compare TrumpRx pricing with pharmacy and insurance options.
Relationship Between TrumpRx and Medicare Drug Pricing
TrumpRx operates separately from Medicare drug price negotiation programs. While some medications may appear in both systems, TrumpRx focuses on direct-to-consumer manufacturer pricing, not government reimbursement rates.
This distinction is important for seniors and Medicare beneficiaries evaluating their options.
Recent Updates and Expansion Plans
As of early 2026, the Trump administration has confirmed that:
- Additional drug manufacturers are in negotiations to join TrumpRx
- The medication list will continue to expand
- More specialty and chronic-care drugs are expected to be added
- The platform will receive usability and transparency updates
The administration has positioned TrumpRx as a long-term component of U.S. drug pricing policy.
Public and Industry Reaction
Public response has been mixed but highly engaged. Many patients report improved price transparency, while industry stakeholders continue to assess the long-term effects on pharmacy networks and insurance models.
What remains clear is that the Trump Rx medication list has introduced a new pricing pathway that did not previously exist at the federal level.
Key Takeaways for U.S. Patients
- TrumpRx is live and operational in 2026
- The Trump Rx medication list includes high-cost brand-name drugs
- Pricing is based on direct manufacturer agreements
- A valid prescription is required
- Patients should compare all pricing options
As the platform evolves, staying informed will help patients make the most cost-effective choices.
What has your experience been with the Trump Rx medication list so far? Share your thoughts below and stay connected as updates continue to roll out.